Elissa spent the past 12 years launching specialty therapeutics and initiatives in the bio-pharmaceutical industry and developing economic policy in the public sector. She most recently lead patient strategy and digital innovation for biosimilar immunology products at Merck, brought their ground-breaking immunotherapy cancer treatment to market and developed their first 24/7 patient support program. Elissa earned her MBA as a Woodruff Fellow at Emory University and her B.A. from Cornell University.
Precision medicine needs financing to fight diseases like cancer. Non-communicable diseases such as cancer and heart disease are an increasing problem in poor countries, but development f...
What's inside an mRNA vaccine vial? How do mRNA vaccines differ from other approaches, and what’s their promise for the future?
Members of the World Economic Forum's Global Future Council explore what's needed to realize synthetic biology's potential - and why we'll need to revisit and rethink the societal transfo...
The World Economic Forum, in partnership with the Lung Ambition Alliance, establishes a taskforce to learn from impact of COVID-19 on lung cancer services.
New alliances are needed to speed the journey of medical innovations from the scientist’s bench to the patient’s bedside across all countries.
A new framework balances ethical tensions to ensure equitable health outcomes globally.
In the race to develop a coronavirus vaccine, the public is repeatedly reminded that the finish line is at least 12 to 18 months away. Here's why.
Countries across the world are realizing that targetted approaches to disease screening and treatment are the future of their healthcare systems.
Le Rwanda fournit des vaccins gratuits contre le virus du papillome humain (VPH) à toutes les filles de 11 à 15 ans et a maintenant immunisé plus de 97 % des filles
En la actualidad, mueren más africanos de cáncer que de malaria. Muchos países africanos están luchando contra el aumento de las tasas de enfermedades no transmisibles (ENT).
The African country has introduced a basic universal health insurance for over 90% of its population, and is using technology to innovate and transform its healthcare system.
Thanks to more personalized healthcare, you will soon spend less time in doctors’ offices, have more peace of mind knowing what is wrong, and experience fewer side effects from trial-and-...
